BioMarin to Participate in Bank of America Merrill Lynch Health Care Conference on May 15 in Las Vegas
May 08 2019 - 8:30AM
PR Newswire (US)
SAN RAFAEL, Calif.,
May 8, 2019 /PRNewswire/
-- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today
announced that Jean-Jacques Bienaimé, Chairman and Chief Executive
Officer, will present at the Bank of America Merrill Lynch Health
Care Conference on May 15 at
11:20am PT/2:20pm ET in Las Vegas. To access the live
webcast, please visit the investor section of the BioMarin website,
www.biomarin.com. A replay will also be archived on the site for at
least one week following each event.
About BioMarin
BioMarin is a global biotechnology company that develops and
commercializes innovative therapies for patients with serious and
life-threatening rare and ultra-rare genetic diseases. The
Company's portfolio consists of several commercial products and
multiple clinical and pre-clinical product candidates for the
treatment of various diseases. For additional information, please
visit www.biomarin.com.
Contacts:
|
|
Investors
|
Media
|
Traci
McCarty
|
Debra
Charlesworth
|
BioMarin
Pharmaceutical Inc.
|
BioMarin
Pharmaceutical Inc.
|
(415)
455-7558
|
(415)
455-7451
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-bank-of-america-merrill-lynch-health-care-conference-on-may-15-in-las-vegas-300842547.html
SOURCE BioMarin Pharmaceutical Inc.
Copyright 2019 PR Newswire
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From Aug 2024 to Sep 2024
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From Sep 2023 to Sep 2024